Increased Prevalence of Metabolic Syndrome in Individuals with Osteoarthritis: An Analysis of NHANES III Data
Top Cited Papers
- 1 November 2009
- journal article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 121 (6) , 9-20
Abstract
Osteoarthritis (OA) and cardiovascular disease (CVD) share age and obesity as risk factors, but may also be linked by pathogenic mechanisms involving metabolic abnormalities and systemic inflammation. This study compared the prevalence of OA and metabolic syndrome (MetS) in subjects with OA versus the general population without OA to determine whether having OA predicts increased cardiovascular risk. National Health and Nutrition Examination Survey III data were used as a representative sample of the general US population. Subjects included adults aged > or = 18 years with records of history, physical, radiographic, and laboratory data adequate to assess for diagnoses of MetS and OA. Logistic regression was used to examine the association between MetS and population-weighted variables. The general population sample included 7714 subjects (weighted value representing 174.9 million population), of whom 975 subjects had OA (weighted value 17.5 million) and 6739 did not (weighted value 157.4 million). Metabolic syndrome was prevalent in 59% of the OA population and 23% of the population without OA. Each of the 5 cardiovascular risk factors that comprise MetS was more prevalent in the OA population versus the population without OA: hypertension (75% vs 38%), abdominal obesity (63% vs 38%), hyperglycemia (30% vs 13%), elevated triglycerides (47% vs 32%), and low high-density lipoprotein cholesterol (44% vs 38%). Metabolic syndrome was more prevalent in subjects with OA regardless of sex or race. The association between OA and MetS was greater in younger subjects and diminished with increasing age. Having OA at age 43.8 years (mean age of the general population) was associated with a 5.26-fold (SE = 1.58, P < 0.001) increased risk of MetS. This association remained strong when obesity was controlled for in additional regression models. Osteoarthritis is associated with an increased prevalence of MetS, particularly in younger individuals. Global cardiovascular risk should be assessed in individuals aged < or = 65 years with OA, and should be considered when prescribing analgesics for OA patients.Keywords
This publication has 55 references indexed in Scilit:
- The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysisBMC Public Health, 2009
- Osteoarthritis and nitric oxideOsteoarthritis and Cartilage, 2008
- Exercise and diet enhance fat oxidation and reduce insulin resistance in older obese adultsJournal of Applied Physiology, 2008
- Topical diclofenac and its role in pain and inflammation: an evidence-based reviewCurrent Medical Research and Opinion, 2008
- Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam StudyAnnals of the Rheumatic Diseases, 2007
- EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Annals of the Rheumatic Diseases, 2007
- Obesity and osteoarthritis: more complex than predicted!Annals of the Rheumatic Diseases, 2006
- Survey of select practice behaviors by primary care physicians on the use of opioids for chronic painCurrent Medical Research and Opinion, 2006
- Primary care provider concerns about management of chronic pain in community clinic populationsJournal of General Internal Medicine, 2006
- Exercise and dietary weight loss in overweight and obese older adults with knee osteoarthritis: The arthritis, diet, and activity promotion trialArthritis & Rheumatism, 2004